The Trump administration revealed the agreements Nov
The big-box retailer is partnering with Novo Nordisk to give members access to popular GLP-1 medications such as Wegovy and Ozempic at half price
1 With the GLP-1 RA class of medication first approved to treat T2D, and then catching a boom in popularity because of its significant weight management capabilities, 4 patients with either obesity or T2D are going to be key populations seeking these medications
That means millions of patients will soon potentially lose access to cheaper, but less regulated, alternatives to the brand name drugs
Research has shown that the net effect of combining the three peptides results in increased GH secretion and IGF-1 levels, increased muscle growth, increased bone density, improved cognitive function and memory, increased cellular repair and regeneration, increased fat loss, and more